ONCIN fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Oncoinvent ASA engages in the development of cancer treatment products. It develops radiopharmaceutical products across a variety of solid cancers. The company was founded by Tina Bjornlund Bonsdorff, Oyvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
ONCIN does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company